The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Phase 3 data expected in the second half of 2024
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Subscribe To Our Newsletter & Stay Updated
